Genetic predisposition to cancer in man: in vitro studies.
D000236:Adenoma / Q000235:genetics*; D000951:Antigens, Neoplasm; D002273:Carcinogens / Q000494:pharmacology; D002455:Cell Division; D002462:Cell Membrane / Q000502:physiology; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism; D003110:Colonic Neoplasms / Q000235:genetics*; D003599:Cytoskeleton / Q000502:physiology; D004198:Disease Susceptibility; D005347:Fibroblasts; D005353:Fibronectins / Q000502:physiology; D005799:Genes, Dominant; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000517:prevention & control; D012004:Rectal Neoplasms / Q000235:genetics*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000951:Antigens, Neoplasm; D002273:Carcinogens; D005353:Fibronectins; D002784:Cholesterol; D013755:Tetradecanoylphorbol Acetate